News
Latest News and Press Releases
Fujifilm and Axcelead Drug Discovery Partners begin collaborating to advance drug discovery solutions using iPSCs
To enhance the Process of Research and Development of Drug Candidates Tokyo/Kanagawa, July 10, 2019 ―FUJIFILM...
Transfer of All Axcelead Shares to Whiz Partners DDG Fund Completed
April 1, 2019 – Whiz Partners Inc. (hereinafter, “Whiz”), headquartered in Minato Ward, Tokyo, announced that it...
Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement
Fujisawa, Japan and Dublin, Ireland, October 4, 2018 – Axcelead Drug Discovery Partners, Inc.(hereinafter referred to as...
Announcement on starting preparation to become a company independent from Takeda
We are pleased to announce that Axcelead Drug Discovery Partners Inc. (“Axcelead”) preparation to become a company...
Announcement of Start of Business Partnership between Axcelead and LAP&P for Modeling and Simulation of Drug Discovery
We are pleased to announce that Axcelead Drug Discovery Partners, Inc. (Yoshinori Ikeura, President; Headquarters: Fujisawa-shi, Kanagawa,...